CELLTRION, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 177,100 KRW | -1.67% |
|
-3.44% | -12.11% |
| 06-17 | Celltrion Reveals Positive Phase III Results of Rheumatoid Arthritis Drug | MT |
| 06-14 | Celltrion, Inc. announces an Equity Buyback for 410,734 shares. | CI |
Trading Ideas
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Trading Ideas
